You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Papaverine Hydrochloride Injection Market Research Report 2021 Professional Edition

Papaverine is a nonxanthine phosphodiesterase inhibitor for the relief of cerebral and peripheral ischemia associated with arterial spasm and myocardial ischemia complicated by arrhythmias. The main actions of Papaverine are exerted on cardiac and smooth muscle. Like qathidine, Papaverine acts directly on the heart muscle to depress conduction and prolong the refractory period. Papaverine relaxes various smooth muscles.
Market Analysis and Insights: Global Papaverine Hydrochloride Injection Market
The global Papaverine Hydrochloride Injection market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Papaverine Hydrochloride Injection Scope and Segment
The global Papaverine Hydrochloride Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Papaverine Hydrochloride Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
30 mg/mL
120 mg/10 mL
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Papaverine Hydrochloride Injection market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developmentss to remain competitive in the market.
The Papaverine Hydrochloride Injection key manufacturers in this market include:
Sandoz
American Regent
Jiangsu Hengrui Medicine
Chengdu Brilliant Pharmaceutical Group
1 Papaverine Hydrochloride Injection Market Overview
1.1 Papaverine Hydrochloride Injection Product Overview
1.2 Papaverine Hydrochloride Injection Market Segment by Type
1.2.1 30 mg/mL
1.2.2 120 mg/10 mL
1.3 Global Papaverine Hydrochloride Injection Market Size by Type
1.3.1 Global Papaverine Hydrochloride Injection Market Size Overview by Type (2016-2027)
1.3.2 Global Papaverine Hydrochloride Injection Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Papaverine Hydrochloride Injection Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Papaverine Hydrochloride Injection Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Papaverine Hydrochloride Injection Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Papaverine Hydrochloride Injection Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Papaverine Hydrochloride Injection Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Papaverine Hydrochloride Injection Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Papaverine Hydrochloride Injection Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Papaverine Hydrochloride Injection Sales Breakdown by Type (2016-2021)
1.4.2 Europe Papaverine Hydrochloride Injection Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Papaverine Hydrochloride Injection Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Papaverine Hydrochloride Injection Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Papaverine Hydrochloride Injection Sales Breakdown by Type (2016-2021)

2 Global Papaverine Hydrochloride Injection Market Competition by Company
2.1 Global Top Players by Papaverine Hydrochloride Injection Sales (2016-2021)
2.2 Global Top Players by Papaverine Hydrochloride Injection Revenue (2016-2021)
2.3 Global Top Players Papaverine Hydrochloride Injection Price (2016-2021)
2.4 Global Top Manufacturers Papaverine Hydrochloride Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Papaverine Hydrochloride Injection Market Competitive Situation and Trends
2.5.1 Papaverine Hydrochloride Injection Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Papaverine Hydrochloride Injection Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Papaverine Hydrochloride Injection as of 2020)
2.7 Date of Key Manufacturers Enter into Papaverine Hydrochloride Injection Market
2.8 Key Manufacturers Papaverine Hydrochloride Injection Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Papaverine Hydrochloride Injection Status and Outlook by Region
3.1 Global Papaverine Hydrochloride Injection Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Papaverine Hydrochloride Injection Historic Market Size by Region
3.2.1 Global Papaverine Hydrochloride Injection Sales in Volume by Region (2016-2021)
3.2.2 Global Papaverine Hydrochloride Injection Sales in Value by Region (2016-2021)
3.2.3 Global Papaverine Hydrochloride Injection Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Papaverine Hydrochloride Injection Forecasted Market Size by Region
3.3.1 Global Papaverine Hydrochloride Injection Sales in Volume by Region (2022-2027)
3.3.2 Global Papaverine Hydrochloride Injection Sales in Value by Region (2022-2027)
3.3.3 Global Papaverine Hydrochloride Injection Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Papaverine Hydrochloride Injection by Application
4.1 Papaverine Hydrochloride Injection Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Papaverine Hydrochloride Injection Market Size by Application
4.2.1 Global Papaverine Hydrochloride Injection Market Size Overview by Application (2016-2027)
4.2.2 Global Papaverine Hydrochloride Injection Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Papaverine Hydrochloride Injection Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Papaverine Hydrochloride Injection Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Papaverine Hydrochloride Injection Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Papaverine Hydrochloride Injection Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Papaverine Hydrochloride Injection Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Papaverine Hydrochloride Injection Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Papaverine Hydrochloride Injection Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Papaverine Hydrochloride Injection Sales Breakdown by Application (2016-2021)
4.3.2 Europe Papaverine Hydrochloride Injection Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Papaverine Hydrochloride Injection Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Papaverine Hydrochloride Injection Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Papaverine Hydrochloride Injection Sales Breakdown by Application (2016-2021)

5 North America Papaverine Hydrochloride Injection by Country
5.1 North America Papaverine Hydrochloride Injection Historic Market Size by Country
5.1.1 North America Papaverine Hydrochloride Injection Sales in Volume by Country (2016-2021)
5.1.2 North America Papaverine Hydrochloride Injection Sales in Value by Country (2016-2021)
5.2 North America Papaverine Hydrochloride Injection Forecasted Market Size by Country
5.2.1 North America Papaverine Hydrochloride Injection Sales in Volume by Country (2022-2027)
5.2.2 North America Papaverine Hydrochloride Injection Sales in Value by Country (2022-2027)

6 Europe Papaverine Hydrochloride Injection by Country
6.1 Europe Papaverine Hydrochloride Injection Historic Market Size by Country
6.1.1 Europe Papaverine Hydrochloride Injection Sales in Volume by Country (2016-2021)
6.1.2 Europe Papaverine Hydrochloride Injection Sales in Value by Country (2016-2021)
6.2 Europe Papaverine Hydrochloride Injection Forecasted Market Size by Country
6.2.1 Europe Papaverine Hydrochloride Injection Sales in Volume by Country (2022-2027)
6.2.2 Europe Papaverine Hydrochloride Injection Sales in Value by Country (2022-2027)

7 Asia-Pacific Papaverine Hydrochloride Injection by Region
7.1 Asia-Pacific Papaverine Hydrochloride Injection Historic Market Size by Region
7.1.1 Asia-Pacific Papaverine Hydrochloride Injection Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Papaverine Hydrochloride Injection Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Papaverine Hydrochloride Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Papaverine Hydrochloride Injection Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Papaverine Hydrochloride Injection Sales in Value by Region (2022-2027)

8 Latin America Papaverine Hydrochloride Injection by Country
8.1 Latin America Papaverine Hydrochloride Injection Historic Market Size by Country
8.1.1 Latin America Papaverine Hydrochloride Injection Sales in Volume by Country (2016-2021)
8.1.2 Latin America Papaverine Hydrochloride Injection Sales in Value by Country (2016-2021)
8.2 Latin America Papaverine Hydrochloride Injection Forecasted Market Size by Country
8.2.1 Latin America Papaverine Hydrochloride Injection Sales in Volume by Country (2022-2027)
8.2.2 Latin America Papaverine Hydrochloride Injection Sales in Value by Country (2022-2027)

9 Middle East and Africa Papaverine Hydrochloride Injection by Country
9.1 Middle East and Africa Papaverine Hydrochloride Injection Historic Market Size by Country
9.1.1 Middle East and Africa Papaverine Hydrochloride Injection Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Papaverine Hydrochloride Injection Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Papaverine Hydrochloride Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Papaverine Hydrochloride Injection Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Papaverine Hydrochloride Injection Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Papaverine Hydrochloride Injection Business
10.1 Sandoz
10.1.1 Sandoz Corporation Information
10.1.2 Sandoz Introduction and Business Overview
10.1.3 Sandoz Papaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Sandoz Papaverine Hydrochloride Injection Products Offered
10.1.5 Sandoz Recent Development
10.2 American Regent
10.2.1 American Regent Corporation Information
10.2.2 American Regent Introduction and Business Overview
10.2.3 American Regent Papaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Sandoz Papaverine Hydrochloride Injection Products Offered
10.2.5 American Regent Recent Development
10.3 Jiangsu Hengrui Medicine
10.3.1 Jiangsu Hengrui Medicine Corporation Information
10.3.2 Jiangsu Hengrui Medicine Introduction and Business Overview
10.3.3 Jiangsu Hengrui Medicine Papaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Jiangsu Hengrui Medicine Papaverine Hydrochloride Injection Products Offered
10.3.5 Jiangsu Hengrui Medicine Recent Development
10.4 Chengdu Brilliant Pharmaceutical Group
10.4.1 Chengdu Brilliant Pharmaceutical Group Corporation Information
10.4.2 Chengdu Brilliant Pharmaceutical Group Introduction and Business Overview
10.4.3 Chengdu Brilliant Pharmaceutical Group Papaverine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Chengdu Brilliant Pharmaceutical Group Papaverine Hydrochloride Injection Products Offered
10.4.5 Chengdu Brilliant Pharmaceutical Group Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Papaverine Hydrochloride Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Papaverine Hydrochloride Injection Industrial Chain Analysis
11.4 Papaverine Hydrochloride Injection Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Papaverine Hydrochloride Injection Distributors
12.3 Papaverine Hydrochloride Injection Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140